Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
 Index 
 Full text 
Verbatim report of proceedings
Tuesday, 11 September 2012 - Strasbourg OJ edition

Explanations of vote
MPphoto
 
 

Text tabled : A7-0165/2012

  Juozas Imbrasas (EFD), in writing. (LT) I voted in favour of a directive of the European Parliament and of the Council amending Directive 2001/83/EC as regards pharmacovigilance. I welcome this amendment because it aims to further strengthen the pharmacovigilance system at EU level. The five additional amendments proposed serve to clarify wording, ensure that the workload of the Pharmacovigilance Risk Assessment Committee remains manageable, and to ensure that patients and health care professionals are fully involved in improving the pharmacovigilance system. Enhancing cooperation between Member States will ensure improved safety of medicines at EU level and will also avoid adverse effects such as in the Mediator case.

 
Legal notice - Privacy policy